METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH MALIGNANT HEMATOLOGICAL DISEASE TO CHEMOTHERAPY TREATMENT AND METHODS OF TREATMENT OF SUCH DISEASE
Ivan CRUZ-MOURA,Valérie BARDET,Michaël DUSSIOT,Thiago TROVATI MACIEL,Jérôme TAMBURINI,Norbert IFRAH,Olivier HERMINE
申请号：
US15550394
公开号：
US20180031579A1
申请日:
2016.02.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to antagonists of GDF11, for use in the treatment of malignant hematological disease, such as Acute Myeloid Leukemia (AML). The present invention also relates to a method for predicting the responsiveness of a patient affected with malignant haematological disease, such as Acute Myeloid Leukemia, to a chemotherapy treatment.
